BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9330128)

  • 1. Effects of selective dopaminergic receptor stimulation on ventricular remodeling after experimental myocardial infarction in rats.
    Teisman AC; van Veldhuisen DJ; Scholtens E; Maselbas W; van Gilst WH
    J Card Fail; 1997 Sep; 3(3):199-205. PubMed ID: 9330128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between myocardial beta-adrenoceptor density and hemodynamic and neurohumoral changes in a rat model of chronic myocardial infarction: effects of ibopamine and captopril.
    van Veldhuisen DJ; Brodde OE; van Gilst WH; Schulze C; Hegeman H; Anthonio RL; Scholtens E; de Graeff PA; Wesseling H; Lie KI
    Cardiovasc Res; 1995 Sep; 30(3):386-93. PubMed ID: 7585830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ibopamine on ventricular remodeling after experimental myocardial infarction: a comparison with captopril.
    van Gilst WH; van Veldhuisen DJ; Hegeman H; Buikema H; Scholtens E; de Graeff PA; Lie KI
    J Cardiovasc Pharmacol; 1994 Jul; 24(1):171-4. PubMed ID: 7521484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurohumoral and hemodynamic effects of ibopamine in a rat model of chronic myocardial infarction and heart failure.
    van Veldhuisen DJ; van Gilst WH; de Smet BJ; de Graeff PA; Scholtens E; Buikema H; Girbes AR; Wesseling H; Lie KI
    Cardiovasc Drugs Ther; 1994 Apr; 8(2):245-50. PubMed ID: 7918137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct vasodilating effects of the new dopaminergic agonist Z1046 in human arteries.
    Teisman AC; Buikema H; van Veldhuisen DJ; de Zeeuw D; van Gilst WH
    J Cardiovasc Pharmacol; 2000 Apr; 35(4):581-5. PubMed ID: 10774789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early pharmacologic intervention may prevent the deterioration in endothelial function after experimental myocardial infarction in rats: effects of ibopamine and captopril.
    Buikema H; van Veldhuisen DJ; Hegeman H; van Gilst WH
    J Card Fail; 1997 Jun; 3(2):125-32. PubMed ID: 9220312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular actions of the dopamine receptor agonist Z1046 in swine.
    Duncker DJ; van Meegen JR; Verdouw PD
    Cardiovasc Drugs Ther; 1997 Sep; 11(4):537-45. PubMed ID: 9358958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic drugs in congestive heart failure: hemodynamic and neuroendocrine responses to ibopamine, dopamine, and dihydroergotoxine.
    Metra M; Missale C; Spano PF; Cas LD
    J Cardiovasc Pharmacol; 1995 May; 25(5):732-40. PubMed ID: 7630152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelium dependent relaxation in two different models of chronic heart failure and the effect of ibopamine.
    Buikema H; van Gilst WH; van Veldhuisen DJ; de Smet BJ; Scholtens E; Lie KI; Wesseling H
    Cardiovasc Res; 1993 Dec; 27(12):2118-24. PubMed ID: 8313417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Z1046: biochemical characterization of its dopaminergic activity.
    Fantoni M; Moriggi E; Bisiani C; Masotto C; Pocchiari F; Semeraro C
    Acta Physiol Hung; 1996; 84(3):279-80. PubMed ID: 9219606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT).
    van Veldhuisen DJ; Man in 't Veld AJ; Dunselman PH; Lok DJ; Dohmen HJ; Poortermans JC; Withagen AJ; Pasteuning WH; Brouwer J; Lie KI
    J Am Coll Cardiol; 1993 Nov; 22(6):1564-73. PubMed ID: 7901256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Z1046: a new specific peripheral dopaminergic compound.
    Ferlenga P; Zanzottera D; Biasini I; Marchini F; Semeraro C
    Acta Physiol Hung; 1996; 84(3):283-4. PubMed ID: 9219608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional capacity in a rat model of heart failure: impact of myocardial infarct size.
    Hentschke VS; Capalonga L; Rossato DD; Perini JL; Alves JP; Quagliotto E; Stefani GP; Karsten M; Pontes M; Dal Lago P
    Exp Physiol; 2017 Nov; 102(11):1448-1458. PubMed ID: 28841254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic response to ibopamine in acute myocardial infarction.
    Taniguchi H; Iwasaka T; Sugiura T; Takayama Y; Sumimoto T; Onoyama H; Takashima H; Nakamura S; Inada M
    Arzneimittelforschung; 1990 Apr; 40(4):428-31. PubMed ID: 2357243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurohormonal and hemodynamic effects of ibopamine.
    Pouleur H
    Clin Cardiol; 1995 Mar; 18(3 Suppl I):I17-21. PubMed ID: 7743694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of mild untreated heart failure during six months follow-up and clinical and neurohumoral effects of ibopamine and digoxin as monotherapy. DIMT Study Group. Dutch Ibopamine Multicenter Trial.
    van Veldhuisen DJ; Brouwer J; Man in 't Veld AJ; Dunselman PH; Boomsma F; Lie KI
    Am J Cardiol; 1995 Apr; 75(12):796-800. PubMed ID: 7717282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dopamine receptor agonist Z1046 reduces ischaemia severity in a canine model of coronary artery occlusion.
    Végh A; Papp JG; Semeraro C; Fatehi-Hasanabad Z; Parratt JR
    Eur J Pharmacol; 1998 Mar; 344(2-3):203-13. PubMed ID: 9600656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of ibopamine on glomerular filtration rate and plasma norepinephrine remain preserved during prolonged treatment in patients with congestive heart failure.
    Lieverse AG; Girbes AR; Van Veldhuisen DJ; Smit AJ; Zijlstra JG; Meijer S; Lie KI; Reitsma WD
    Eur Heart J; 1995 Jul; 16(7):937-42. PubMed ID: 7498209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of beta-adrenergic blocking agent treatment on hemodynamic function and left ventricular remodeling in rats with experimental myocardial infarction: importance of timing of treatment and infarct size.
    Hu K; Gaudron P; Ertl G
    J Am Coll Cardiol; 1998 Mar; 31(3):692-700. PubMed ID: 9502655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.